1st Quarter - Amendment

BLANK ROME GOVERNMENT RELATIONS for MYLAN LABORATORIES INC

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 18, 2008 $50,000 Replaced
1st Quarter - Amendment Jul 30, 2010 $50,000 Replaced
1st Quarter - Amendment (this page) Aug 3, 2010 $50,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the generic drug industry, authorized generics, patent settlement, citizen petitions, generic biologics, Medicaid/Medicare, BioShield, President's Emergency Plan for AIDS Relief (PEPFAR) and FDA issues.

LobbyistCovered position, as disclosed
KELLY BOBEK —
MICHELLE CASTRO —
ASHLEY DAVIS —
JAMES DREWRY —
JOHN MANISCALCO —
PETER A PEYSER —
KRISTI REMINGTON Deputy Attorney General

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.